S. Korean biotech snags financing with help from U.S. venture group

Posted under Blog, Companies, CrystalGenomics, Diagnostics, Funding, Medical Devices, Medical Supply, osteoarthritis, Oxford Bioscience Partners, Pharmaceuticals, Startups, Universities, Videos by Ryan McBride

South Korea-based CrystalGenomics has reeled in $2.6 million in funding from the Korea Seoul Life Science Fund (KSLSF) to advance its R&D programs in pain and infectious diseases, including an NSAID for patients with osteoarthritis, according to a company release. The company noted U.S. venture firm Oxford Bioscience Partners and Hanwha Venture Capital's roles as general partners in its backer KSLSF. The government of South Korea was a major contributor to Boston-based Oxford's sixth fund announced in early 2011. Release